Loading
Life sciences · Journal article
ماهنامه علمی پژوهشی دانشگاه علوم پزشکی شهید صدوقی یزد · September 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Introduction: Obesity represent a complex, chronic, and relapsing medical disorder. The associated global mortality and socioeconomic burden remain considerable worldwide. Innovative pharmacological interventions, such as GLP-1 receptor agonists (e.g., Tirzepatide), have fundamentally changed clinical weight management. Meanwhile, Metabolic surgery remains the most durable option for high risk patients. Consequently, healthcare systems must accept obesity as a chronic disease entity and provide insurance coverage for both medical and surgical treatments to promote equity across public healthcare.